Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Biomaterials. 2008 Mar 4;29(14):2270–2279. doi: 10.1016/j.biomaterials.2008.01.028

Figure 5.

Figure 5

Cytotoxicities of NS-HER and NS with various concentrations of herceptin, as measured by the viabilities of SK-Br-3 cells grown in media containing 0.2 mg/ml of these nanospheres relative to the non-toxic control. Results are represented as mean ± standard deviation. “*” denotes statistical differences (P < 0.05) compared to the control experiment.